Allergan Reiterates Strategic Focus is Growth in Specialty Pharmaceutical Business.Business Editors & Health/Medical Writers IRVINE, Calif.--(BW HealthWire)--April 18, 2001 In response to questions from investors regarding Allergan being mentioned in the Schedule 13D Schedule 13D An form that must be filed with the SEC under Rule 13D when a person or group acquiring more than 5% of any class of a company's shares to disclose this information within 10 days of the transaction. filed today by Icahn Associates Corp. with respect to VISX, Incorporated, and in compliance with Regulation FD, Allergan, Inc. (NYSE NYSE See: New York Stock Exchange : AGN AGN Again (Amateur Radio) AGN Active Galactic Nucleus AGN Acute Glomerulonephritis AGN Accountants Global Network AGN Air Gabon (ICAO code) ) issued the following statement: As a matter of policy, Allergan does not comment on market rumors and speculation. As repeated on many occasions, Allergan's strategic focus continues to be the growth of its specialty pharmaceutical business primarily through its own research and development pipeline. The Company considers strategic opportunities that would directly enhance its specialty pharmaceutical business as its first priority. Allergan, Inc., headquartered in Irvine, California Irvine is an incorporated city in Orange County, California, United States. It is a planned city, mainly developed by the Irvine Company since the 1960s. Formally incorporated on December 28 1971, the 69.7 square mile (180.5 km²) city has a population of 202,079 (as of 2007). , is a technology-driven global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens contact lens, thin plastic lens worn between the eye and eyelid that may be used instead of eyeglasses. Actors, models, and others wear them for appearance, and athletes use them for safety and convenience. care, movement disorder, and dermatological markets that deliver value to our customers, satisfy unmet medical needs, and improve patients' lives. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion